Compound ID | 1795
Debio1454
Class: Fatty acid synthesis inhibitor (FabI inhibitor)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Inhibits FabI, which determins the completing of each cycle of elongation in the fatty acid synthesis. Active against Acinetobater baumannii. |
| Description: | Synthetic compound |
| Institute where first reported: | Debiopharm International SA |
| Year first mentioned: | 2019 |
| Highest developmental phase: | Preclinical |
| Development status: | Active (as of 2022) |
| External links: | |
| Citation: | https://www.escmid.org/guidelines_publications/escmid_elibrary/material/?mid=29563 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.